The DOI matches its Crossref record.
ABNORMAL ELECTROLYTE COMPOSITION OF SWEAT IN CYSTIC FIBROSIS OF THE PANCREAS
Abstract
The electrolyte composition of sweat secreted in response to a standard mild thermal stimulus was found to be abnormal in 43 patients with cystic fibrosis of the pancreas. Sodium and chloride concentrations in sweat were 2 to 4 times as high as those found in 50 patients with a variety of other diseases. Sweat potassium levels were also increased in cystic fibrosis of the pancreas although not to the same extent. In contrast, the amount of sweat was not significantly different in patients with fibrocystic disease of the pancreas and control patients. It was shown that pancreatic deficiency, chronic pulmonary disease and the administration of certain drugs do not per se affect the electrolyte composition of sweat. It was also demonstrated by metabolic studies that disturbances in renal and adrenal function are not responsible for the high sweat chloride and sodium in fibrocystic disease. The dissociation between increased electrolytes in the sweat and their very low levels in the urine during salt restriction are unique to this condition. The fact that the sweat glands do not retain salt effectively in hot weather, during salt restriction or when DCA is administered, points to a disturbance in the sweat glands themselves. This abnormality may not be pathognomonic of cystic fibrosis of the pancreas, but it is an expected finding. These disturbances in sweat composition together with preliminary observations of abnormal salivary gland secretion suggest that the secretory activity of many and perhaps all exocrine glands is affected in cystic fibrosis of the pancreas. The term "mucoviscidosis" does not seem justified in view of the fact that at least two nonmucus-secreting structures are affected in this condition. Massive salt loss through sweating in hot weather accounts satisfactorily for the "heat casualties" in cystic fibrosis of the pancreas. The mechanisms are discussed and it is emphasized that the symptoms are initiated by pure salt loss and the consequent reduction in extracellular fluid volume. Since the condition may, if not treated, lead to fatal cardiovascular collapse, it should be regarded as an acute medical emergency. Under the usual circumstances, serum electrolyte concentrations are normal in fibrocystic disease of the pancreas. In the presence of marked pulmonary dysfunction in this disease, the bicarbonate of the plasma is elevated and the chloride reduced in compensation. It is therefore necessary to demonstrate a lowered serum sodium as well as chloride to detect the massive salt loss which may occur in hot weather.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Physiology of sweat gland function: The roles of sweating and sweat composition in human health
Baker, L. B. (2019) · Temperature · doi:10.1080/23328940.2019.1632145 · Cited by 732
Davis, P. B. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-840oe · Cited by 670
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes-Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 535
Metadata
- Authors
- DI SANT'AGNESE, P. A., DARLING, R. C., PERERA, G. A., & SHEA, E.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1953-11-01
- Volume
- 12
- Issue
- 5
- Pages
- 549-563
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1605262540
- Cited by
- 546
- References
- 0
- FWCI
- 13.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ABNORMAL ELECTROLYTE COMPOSITION OF SWEAT IN CYSTIC FIBROSIS OF THE PANCREAS. https://app.cochat.ai/papers/10.1542/peds.12.5.549
- The paper
- DI SANT'AGNESE, P. A., DARLING, R. C., PERERA, G. A., & SHEA, E. (1953). ABNORMAL ELECTROLYTE COMPOSITION OF SWEAT IN CYSTIC FIBROSIS OF THE PANCREAS. Pediatrics. https://doi.org/10.1542/peds.12.5.549
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.